Burden of NASH related liver cancer from 1990 to 2021 at the global, regional, and national levels

BackgroundThe global burden of non-alcoholic steatohepatitis (NASH)-related liver cancer (NRLC) is increasing, making NASH the fastest-growing cause of liver cancer worldwide. This study presents a comprehensive analysis of NRLC burden at the global, regional, and national levels, further categorize...

Full description

Saved in:
Bibliographic Details
Main Authors: Shuang Li, Shuangjiang Li, Linjing Guan, Mingjuan Li, Jiahui Zhao, Min Wu, Qiuyun Li, Hui Li, Guoqing Ouyang, Guangdong Pan
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Nutrition
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnut.2025.1510563/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832585096832483328
author Shuang Li
Shuang Li
Shuangjiang Li
Linjing Guan
Mingjuan Li
Jiahui Zhao
Min Wu
Qiuyun Li
Hui Li
Guoqing Ouyang
Guangdong Pan
Guangdong Pan
author_facet Shuang Li
Shuang Li
Shuangjiang Li
Linjing Guan
Mingjuan Li
Jiahui Zhao
Min Wu
Qiuyun Li
Hui Li
Guoqing Ouyang
Guangdong Pan
Guangdong Pan
author_sort Shuang Li
collection DOAJ
description BackgroundThe global burden of non-alcoholic steatohepatitis (NASH)-related liver cancer (NRLC) is increasing, making NASH the fastest-growing cause of liver cancer worldwide. This study presents a comprehensive analysis of NRLC burden at the global, regional, and national levels, further categorized by age, sex, and sociodemographic index (SDI).MethodData on NRLC from the Global Burden of Disease, Injuries, and Risk Factors (GBD) study 2021 were downloaded at global, regional, and national levels. The numbers and age-standardized rates (ASRs) of incidence, mortality, and disability-adjusted life years (DALYs) were analyzed to quantify the global burden of NRLC. Additionally, percentage changes in ASRs were used to identify trends in NRLC from 1990 to 2021.ResultsGlobally, both the number of cases and ASRs for NRLC increased between 1990 and 2021. In 2021, there were 42,291 new cases, 40,925 deaths, and 995,475 DALYs attributed to NRLC. East Asia, South Asia, and Southeast Asia reported the highest absolute case numbers, while Western, Southern, and Eastern Sub-Saharan Africa exhibited the highest ASRs. From 1990 to 2021, Australasia, Southern Latin America, and High-income North America showed the most significant increases in NRLC incidence. Nationally, Mongolia, Gambia, and Mozambique exhibited the highest ASR in 2021.The greatest percentage increases in ASIR occurred in Australia, the United Kingdom, and New Zealand between 1990 and 2021. NRLC incidence rates were higher in men and increased with age, peaking at 80–89 years. Similar patterns were observed for NRLC-related deaths and DALYs. Regionally, ASRs initially declined but then increased as SDI rose. At the national level, ASRs consistently decreased with higher SDI.ConclusionThis study highlights the substantial burden of NRLC at global, regional, and national levels. Males and older individuals bear a higher disease burden, and considerable variation exists across different regions and countries. These findings provide critical insights for formulating effective strategies to prevent and manage NRLC.
format Article
id doaj-art-c9a7c8c26078475c960ab0ed4d4d2749
institution Kabale University
issn 2296-861X
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Nutrition
spelling doaj-art-c9a7c8c26078475c960ab0ed4d4d27492025-01-27T05:14:29ZengFrontiers Media S.A.Frontiers in Nutrition2296-861X2025-01-011210.3389/fnut.2025.15105631510563Burden of NASH related liver cancer from 1990 to 2021 at the global, regional, and national levelsShuang Li0Shuang Li1Shuangjiang Li2Linjing Guan3Mingjuan Li4Jiahui Zhao5Min Wu6Qiuyun Li7Hui Li8Guoqing Ouyang9Guangdong Pan10Guangdong Pan11Graduate School of Guangxi University of Chinese Medicine, Nanning, Guangxi, ChinaDepartment of General Surgery, Liuzhou People’s Hospital, Liuzhou, Guangxi, ChinaDepartment of General Surgery, Liuzhou People’s Hospital, Liuzhou, Guangxi, ChinaDepartment of Abdomen Ultrasound, Nanning Sixth People’s Hospital, Nanning, Guangxi, ChinaDepartment of General Surgery, Liuzhou People’s Hospital, Liuzhou, Guangxi, ChinaDepartment of General Surgery, Liuzhou People’s Hospital, Liuzhou, Guangxi, ChinaDepartment of General Surgery, Liuzhou People’s Hospital, Liuzhou, Guangxi, ChinaDepartment of General Surgery, Liuzhou People’s Hospital, Liuzhou, Guangxi, ChinaDepartment of Respiratory Medicine, The First Hospital of Changsha, Changsha, Hunan, ChinaDepartment of General Surgery, Liuzhou People’s Hospital, Liuzhou, Guangxi, ChinaGraduate School of Guangxi University of Chinese Medicine, Nanning, Guangxi, ChinaDepartment of General Surgery, Liuzhou People’s Hospital, Liuzhou, Guangxi, ChinaBackgroundThe global burden of non-alcoholic steatohepatitis (NASH)-related liver cancer (NRLC) is increasing, making NASH the fastest-growing cause of liver cancer worldwide. This study presents a comprehensive analysis of NRLC burden at the global, regional, and national levels, further categorized by age, sex, and sociodemographic index (SDI).MethodData on NRLC from the Global Burden of Disease, Injuries, and Risk Factors (GBD) study 2021 were downloaded at global, regional, and national levels. The numbers and age-standardized rates (ASRs) of incidence, mortality, and disability-adjusted life years (DALYs) were analyzed to quantify the global burden of NRLC. Additionally, percentage changes in ASRs were used to identify trends in NRLC from 1990 to 2021.ResultsGlobally, both the number of cases and ASRs for NRLC increased between 1990 and 2021. In 2021, there were 42,291 new cases, 40,925 deaths, and 995,475 DALYs attributed to NRLC. East Asia, South Asia, and Southeast Asia reported the highest absolute case numbers, while Western, Southern, and Eastern Sub-Saharan Africa exhibited the highest ASRs. From 1990 to 2021, Australasia, Southern Latin America, and High-income North America showed the most significant increases in NRLC incidence. Nationally, Mongolia, Gambia, and Mozambique exhibited the highest ASR in 2021.The greatest percentage increases in ASIR occurred in Australia, the United Kingdom, and New Zealand between 1990 and 2021. NRLC incidence rates were higher in men and increased with age, peaking at 80–89 years. Similar patterns were observed for NRLC-related deaths and DALYs. Regionally, ASRs initially declined but then increased as SDI rose. At the national level, ASRs consistently decreased with higher SDI.ConclusionThis study highlights the substantial burden of NRLC at global, regional, and national levels. Males and older individuals bear a higher disease burden, and considerable variation exists across different regions and countries. These findings provide critical insights for formulating effective strategies to prevent and manage NRLC.https://www.frontiersin.org/articles/10.3389/fnut.2025.1510563/fullincidencedeathdisability-adjusted life yearsage-standardized rateNASH-related liver cancer
spellingShingle Shuang Li
Shuang Li
Shuangjiang Li
Linjing Guan
Mingjuan Li
Jiahui Zhao
Min Wu
Qiuyun Li
Hui Li
Guoqing Ouyang
Guangdong Pan
Guangdong Pan
Burden of NASH related liver cancer from 1990 to 2021 at the global, regional, and national levels
Frontiers in Nutrition
incidence
death
disability-adjusted life years
age-standardized rate
NASH-related liver cancer
title Burden of NASH related liver cancer from 1990 to 2021 at the global, regional, and national levels
title_full Burden of NASH related liver cancer from 1990 to 2021 at the global, regional, and national levels
title_fullStr Burden of NASH related liver cancer from 1990 to 2021 at the global, regional, and national levels
title_full_unstemmed Burden of NASH related liver cancer from 1990 to 2021 at the global, regional, and national levels
title_short Burden of NASH related liver cancer from 1990 to 2021 at the global, regional, and national levels
title_sort burden of nash related liver cancer from 1990 to 2021 at the global regional and national levels
topic incidence
death
disability-adjusted life years
age-standardized rate
NASH-related liver cancer
url https://www.frontiersin.org/articles/10.3389/fnut.2025.1510563/full
work_keys_str_mv AT shuangli burdenofnashrelatedlivercancerfrom1990to2021attheglobalregionalandnationallevels
AT shuangli burdenofnashrelatedlivercancerfrom1990to2021attheglobalregionalandnationallevels
AT shuangjiangli burdenofnashrelatedlivercancerfrom1990to2021attheglobalregionalandnationallevels
AT linjingguan burdenofnashrelatedlivercancerfrom1990to2021attheglobalregionalandnationallevels
AT mingjuanli burdenofnashrelatedlivercancerfrom1990to2021attheglobalregionalandnationallevels
AT jiahuizhao burdenofnashrelatedlivercancerfrom1990to2021attheglobalregionalandnationallevels
AT minwu burdenofnashrelatedlivercancerfrom1990to2021attheglobalregionalandnationallevels
AT qiuyunli burdenofnashrelatedlivercancerfrom1990to2021attheglobalregionalandnationallevels
AT huili burdenofnashrelatedlivercancerfrom1990to2021attheglobalregionalandnationallevels
AT guoqingouyang burdenofnashrelatedlivercancerfrom1990to2021attheglobalregionalandnationallevels
AT guangdongpan burdenofnashrelatedlivercancerfrom1990to2021attheglobalregionalandnationallevels
AT guangdongpan burdenofnashrelatedlivercancerfrom1990to2021attheglobalregionalandnationallevels